Logo

Millipore Posts 38-Percent Rise in Q3 Revenue as Profit Slips 35 Percent

Nov 02, 2006
NEW YORK (GenomeWeb News) — Millipore yesterday said third-quarter revenues increased 38 percent as R&D spending rose 31 percent and profits slid 35 percent.
 
Total receipts for the three months ended Sept. 30 increased to $330.1 million from $239.6 million year over year. Compared with the third quarter of 2005, sales in the company’s Bioprocess segment was up 34 percent to $195 million, while its Bioscience segment gained 44 percent with sales of $135 million.
 
R&D spending increased to $24.6 million from $18.9 million year over year.
 
The company said profits declined to $14.8 million from $22.9 million in the year-ago period.
 
Millipore said it had around $91.4 million in cash and cash equivalents as of Sept. 30.

Breaking News
The Scan

Wolf Howl Responses Offer Look at Vocal Behavior-Related Selection in Dogs

In dozens of domestic dogs listening to wolf vocalizations, researchers in Communication Biology see responses varying with age, sex, reproductive status, and a breed's evolutionary distance from wolves.

Facial Imaging-Based Genetic Diagnoses Appears to Get Boost With Three-Dimensional Approach

With data for more than 1,900 individuals affected by a range of genetic conditions, researchers compared facial phenotype-based diagnoses informed by 2D or 3D images in the European Journal of Human Genetics.

Survey Suggests Multigene Cancer Panel VUS Reporting May Vary Across Genetic Counselors

Investigators surveyed dozens of genetic counselors working in clinical or laboratory settings, uncovering attitudes around VUS reporting after multigene cancer panel testing in the Journal of Genetic Counseling.

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.